Effects of consumer adverse event reporting for a monoclonal antibody indicated in a paediatric population on risk communication tools

被引：0

作者：

Oladipo, A. ^{[1
]}

Mendelsohn, A. B. ^{[1
]}

Roncal, J. ^{[1
]}

Yonren, S. ^{[1
]}

机构：

[1] Medimmune Inc, Prod Safety Dept, Gaithersburg, MD 20878 USA

来源：

DRUG SAFETY | 2006年 / 29卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：945 / 945

页数：1

共 8 条

[1] ADVERSE EVENT REPORTING OF MARKETING BIOSIMILAR AND BIOLOGICAL MONOCLONAL ANTIBODY CANCER TREATMENTS
Xue, X. Xiangzhong
Qian, J.
[J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (03): : 564 - 564
[2] Does the spontaneous adverse event reporting pattern for a monoclonal antibody exhibit the Weber effect?
Oladipo, A.
Mendelsohn, A. B.
Yonren, S.
[J]. DRUG SAFETY, 2006, 29 (10) : 938 - 938
[3] Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States
Xue, Xiangzhong
Truong, Bang
Qian, Jingjing
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 841 - 849
[4] ADVERSE EVENT REPORTING OF MARKETED BIOSIMILAR AND BIOLOGICAL MONOCLONAL ANTIBODY CANCER TREATMENTS IN THE UNITED STATES
Xue, X.
Truong, B.
Qian, J.
[J]. VALUE IN HEALTH, 2023, 26 (06) : S365 - S366
[5] Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system
Zhao, Jiawei
Tao, Yong
[J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
[6] When Bad Things Happen: Adverse Event Reporting and Disclosure as Patient Safety and Risk Management Tools in the Neonatal Intensive Care Unit
Donn, Steven M.
McDonnell, William M.
[J]. AMERICAN JOURNAL OF PERINATOLOGY, 2012, 29 (01) : 65 - 69
[7] QT-prolonging effects of monoclonal antibody drugs in humans: a systematic review of two literature and a public adverse event database
Jackson, Torquil
Kondic, Jelena
Seebeck, Joerg
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (09) : 705 - 711
[8] Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database
Xue, Xiangzhong
Qian, Jingjing
[J]. EXPERT OPINION ON DRUG SAFETY, 2024,

← 1 →